The Massachusetts Consortium on Pathogen Readiness (MassCPR), a multi-institutional initiative convened by Harvard Medical School to combat the disease and prepare for future outbreaks, on May 13 announced over $16.5 million in funding to support 62 research projects that address the most pressing challenges of the pandemic. The initiative includes scientists and clinicians from Harvard, MIT, … Continued
A Harvard-developed tool lets policymakers base their economic decisions on fresh information. Called the Opportunity Insights Economic Tracker, the tool was created as a public resource to help policymakers assess the effects of the downturn in different regions of the U.S. with the most up-to-date information possible. With a more complete and current picture of the … Continued
Chan School’s Koenen discusses rising mental health concerns in the coronavirus era. This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring.
Researchers at MIT; the Ragon Institute of MGH, MIT, and Harvard; and the Broad Institute of MIT and Harvard; along with colleagues from around the world have identified specific types of cells that appear to be targets of the coronavirus that is causing the Covid-19 pandemic. Using existing data on the RNA found in different … Continued
In partnership with the Broad Institute of MIT and Harvard, Biogen has formed a consortium that will build and share a COVID-19 biobank.
Clear answers to common questions relating to the coronavirus by Harvard Health Publishing at the Harvard Medical School. New questions and updated answers are added continually reliable information becomes available.
Coronavirus patients in areas that had high levels of air pollution before the pandemic are more likely to die from the infection than patients in cleaner parts of the country, according to a new nationwide study that offers the first clear link between long-term exposure to pollution and COVID-19 death rates. In an analysis of 3,080 … Continued
At a historic meeting held Monday at Harvard Medical School, more than 80 clinicians and scientists came together to commit to a Covid-19 response In this unprecedented endeavor, this consortium is partnering with fellow clinicians and scientists at the heart of the epidemic in China, who hold critical pieces to the puzzle.
Companies like Alnylam, Moderna, and Thermo Fisher are mobilizing As Massachusetts braces for a surge of patients infected with the coronavirus, the state is playing an outsize role in the global fight against the pandemic. Companies in the state are scrambling to develop and distribute potential vaccines, drugs, and diagnostic tests.
Researchers in the Blavatnik Institute at Harvard Medical School (HMS) and at Brigham and Women’s Hospital are adapting an antibody-detection tool to study the aftermath of infections by the novel coronavirus that is causing the current global pandemic. The goal is to analyze blood samples from people who recover from infection to learn about how … Continued